![]() |
市場調查報告書
商品編碼
1453852
免疫測量的全球市場 2024-2028Global Radioimmunoassay Market 2024-2028 |
2023-2028年免疫測量市場規模預估為17.3億美元,預測期內複合年成長率為4.82%。
該報告包括對免疫測量市場的總體分析、市場規模/預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。
它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由製藥和生物技術行業的擴張、感染疾病的流行以及老年人口的增加所推動的。
市場範圍 | |
---|---|
基準年 | 2024年 |
結束年份 | 2028年 |
預測期 | 2024-2028 |
成長動力 | 加速度 |
2024年與前一年同期比較 | 3.83% |
複合年成長率 | 4.82% |
增量 | 17.3億美元 |
研究指出,免疫測量系統的自動化和整合將是未來幾年推動免疫測量市場成長的關鍵因素之一。此外,基於免疫測量的照護現場設備市場的開拓以及對個人化醫療的日益重視預計將帶來巨大的市場需求。
The radioimmunoassay market is forecasted to grow by USD 1.73 bn during 2023-2028, accelerating at a CAGR of 4.82% during the forecast period. The report on the radioimmunoassay market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of pharmaceutical and biotechnology industries, rise in prevalence of infectious diseases, and growing geriatric population.
Technavio's radioimmunoassay market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 3.83% |
CAGR | 4.82% |
Incremental Value | $1.73bn |
By Application
By Product
By Geographical Landscape
This study identifies the shift towards automation and integration into radioimmunoassay systems as one of the prime reasons driving the radioimmunoassay market growth during the next few years. Also, development of radioimmunoassay-based point-of-care devices and increasing emphasis on personalized medicine will lead to sizable demand in the market.
The report on the radioimmunoassay market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radioimmunoassay market vendors that include ALPCO, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Danaher Corp., Enzo Biochem Inc., Merck KGaA, MP BIOMEDICALS, OriGene Technologies Inc., PerkinElmer Inc, Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the radioimmunoassay market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: